ALXN News and Press, Alexion Pharmaceuticals Inc. From 05/17/20

Portola Pharmaceuticals (NASDAQ: PTLA ) is a $1.4 billion corporation that was recently acquired by Alexion Pharmaceuticals (NASDAQ: ALXN ). The two companies entered a definitive merger agreement, which we discussed and recommend reading about here . As we'll see throughout this article, r...

Alexion Pharmaceuticals (NASDAQ: ALXN ) is a more than $20 billion company that has announced it is acquiring Portola Pharmaceuticals (NASDAQ: PTLA ) for $1.45 billion. That represents an acquisition worth almost 8% of the company’s market capitalization. Given Alexion Pharmaceuticals...

- Accepted abstracts include interim Phase 2 extension data demonstrating reduced duration of infusion with ULTOMIRIS ® (ravulizumab-cwvz) 100 mg/mL formulation - - Data from five abstracts demonstrate Alexion’s continued commitment to advancing the understanding of PNH wi...

Original Post Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...

Calling a purchase of Portola Pharmaceuticals (NASDAQ: PTLA ) the "wrong direction," Elliott Advisors suggests Alexion (NASDAQ: ALXN ) instead put itself on the block. More news on: Alexion Pharmaceuticals, Inc., Portola Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Me...

Merger activity increased last week with three new deals announced, four deals closing and one deal terminated. After a three-week lull, merger activity picked up again with three new deals announced. The hard-hit energy services industry saw the merger of KLX Energy Services Holdings (KLX...

Three months ago, I brought a " Perfect Piotroski " portfolio to the Seeking Alpha community. The goal was to see if a collection made up of companies that scored a nine on the Piotroski score performed better than the market as a whole. At the time of writing, the economy was looking good. ...

Alexion Pharmaceuticals ( ALXN ) surprised the market by announcing an acquisition in the middle of the Covid-19 crisis as it is looking to acquire Portola Pharmaceuticals ( PTLA ) . Thanks to generous cash flows, Alexion has the means and willingness to be aggressive in dealmaking, havin...

By Breakingviews Alexion Pharmaceuticals (ALXN) is either buying Portola Pharmaceuticals (PTLA) on the cheap at $1.4 billion, or paying a whopping premium - it all depends on your starting date. The deal means the $22 billion biotech snaps up a promising drug to reverse anticoagulants. The...

Many of the companies included in this article are in the mix developing treatments for COVID-19, some already have possible therapies in place. But perhaps the thing they have in common the most is how their price charts are governed largely by investor sentiment. Most of these names sold off...